(Q39794252)

14 September 2017

title

Dysregulation of hepatocyte cell cycle and cell viability by hepatitis B virus (English)

1 reference

14 September 2017

1 reference

7

1 reference

14 September 2017

Joseph Torresi

9

0 references

John Silke

object named as

John Silke

8

0 references

author name string

Ruth Chin

1

1 reference

14 September 2017

Ulrich Nachbur

2

1 reference

14 September 2017

Linda Earnest-Silveira

3

1 reference

14 September 2017

Aleksandra Bankovacki

4

1 reference

14 September 2017

Bernd Koeberlein

5

1 reference

14 September 2017

Hanswalter Zentgraf

6

1 reference

14 September 2017

publication date

26 September 2009

1 reference

14 September 2017

1 reference

14 September 2017

volume

147

1 reference

14 September 2017

issue

1

1 reference

14 September 2017

page(s)

7-16

1 reference

Involvement of the interaction between p21 and proliferating cell nuclear antigen for the maintenance of G2/M arrest after DNA damage.

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

High risk of hepatocellular carcinoma in anti-HBe positive liver cirrhosis patients developing lamivudine resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Cell cycle arrest and DNA endoreduplication following p21Waf1/Cip1 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Transformation of rodent fibroblasts by herpes simplex virus: Presence of morphological transforming region 1 (MTR 1) is not required for the maintenance of the transformed state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Subcellular mislocalization of mutant hepatitis B X proteins contributes to modulation of STAT/SOCS signaling in hepatocellular carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

The enigmatic X gene of hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Requirement for p53 and p21 to sustain G2 arrest after DNA damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Modulation of MAPK pathways and cell cycle by replicating hepatitis B virus: factors contributing to hepatocarcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Deactivation of Akt and STAT3 signaling promotes apoptosis, inhibits proliferation, and enhances the sensitivity of hepatocellular carcinoma cells to an anticancer agent, Atiprimod

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Activation of extracellular signal-regulated kinase (ERK) in G2 phase delays mitotic entry through p21CIP1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Cellular survival: a play in three Akts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-kappaB pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Targeting RAS signalling pathways in cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Nuclear accumulation of p21Cip1 at the onset of mitosis: a role at the G2/M-phase transition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Survival and apoptosis: a dysregulated balance in liver cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Lost in transcription: p21 repression, mechanisms, and consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Cooperative repression of cyclin-dependent kinase inhibitor p21 gene expression by hepatitis B virus X protein and hepatitis C virus core protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

The p53 pathway: positive and negative feedback loops

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Management of hepatitis B: summary of a clinical research workshop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Predicting cirrhosis risk based on the level of circulating hepatitis B viral load

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

The IkappaB kinase - a bridge between inflammation and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

NF-kappaB: linking inflammation and immunity to cancer development and progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Fatal submassive hepatic necrosis associated with tyrosine-methionine-aspartate-aspartate-motif mutation of hepatitis B virus after long-term lamivudine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

The hepatitis B virus X protein sensitizes HepG2 cells to UV light-induced DNA damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Hepatitis B virus X protein differentially regulates cell cycle progression in X-transforming versus nontransforming hepatocyte (AML12) cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Function and regulation of ras.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

G1 cell-cycle control and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Akt-mediated liver growth promotes induction of cyclin E through a novel translational mechanism and a p21-mediated cell cycle arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Effect of hepatocyte proliferation and cellular DNA synthesis on hepatitis B virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Hepatitis B virus X protein protects against anti-Fas-mediated apoptosis in human liver cells by inducing NF-kappa B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Induced oxidative stress and activated expression of manganese superoxide dismutase during hepatitis C virus replication: role of JNK, p38 MAPK and AP-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Glycogen synthase kinase-3 couples AKT-dependent signaling to the regulation of p21Cip1 degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Akt-dependent phosphorylation of p21(Cip1) regulates PCNA binding and proliferation of endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Signaling networks that link cell proliferation and cell fate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Hepatitis B virus X protein activates the p38 mitogen-activated protein kinase pathway in dedifferentiated hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Paracrine in vivo inhibitory effects of hepatitis B virus X protein (HBx) on liver cell proliferation: an alternative mechanism of HBx-related pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Fatal hepatic failure after emergence of the hepatitis B virus mutant during lamivudine therapy in a patient with liver cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Human hepatitis B virus X protein promotes cell proliferation and inhibits cell apoptosis through interacting with a serine protease Hepsin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Possible mechanism for hepatitis B virus X gene to induce apoptosis of hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

Overexpression of p53 protein is not directly related to hepatitis B x protein expression and is associated with neoplastic progression in hepatocellular carcinomas rather than hepatic preneoplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.09.012

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIRUSRES.2009.09.012

1 reference

14 September 2017

1 reference